By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunomedics, Inc. 

300 American Road

Morris Plains  New Jersey  07950-2450  U.S.A.
Phone: 201-605-8200 Fax: 973-605-8282



Company News
Immunomedics, Inc. (IMMU) Awarded Fast Track Designation By FDA For Sacituzumab Govitecan For Non-Small Cell Lung Cancer Therapy 5/15/2015 11:04:06 AM
Immunomedics, Inc. (IMMU) Awarded $1.2 Million Department Of Defense Grant For Development Of ARA-LAMP-Vax Peanut Allergy Vaccine 5/13/2015 7:49:11 AM
Immunomedics, Inc. (IMMU) Extends U.S. Patent Protection For Sacituzumab Govitecan To 2033 5/12/2015 7:41:34 AM
Immunomedics, Inc. (IMMU) Announces Third Quarter Fiscal 2015 Results And Clinical Program Developments 5/7/2015 8:04:34 AM
Immunomedics, Inc. (IMMU) Announces Conference Call And Webcast For Third Quarter Fiscal 2015 Financial Results 4/30/2015 8:27:52 AM
Patients With Advanced Breast, Lung, Esophageal, And Colorectal Cancers Respond To Immunomedics, Inc. (IMMU)' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments 4/20/2015 2:23:09 PM
Immunomedics, Inc. (IMMU) To Provide Update On Sacituzumab Govitecan For The Therapy Of Solid Cancers 4/6/2015 7:07:47 AM
Immunomedics, Inc. (IMMU) Presents Updated Results With Sacituzumab Govitecan in Lung Cancer 2/20/2015 7:26:10 AM
Immunomedics, Inc. (IMMU) Announces Completion Of Offering Of $85 Million Of 4.75% Convertible Senior Notes Due 2020 2/12/2015 7:29:14 AM
Immunomedics, Inc. (IMMU) Announces Pricing Of Offering of $85 Million Of 4.75% Convertible Senior Notes Due 2020 2/6/2015 7:38:09 AM